Eurofins Scientific SE (ERFSF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:42PM EDT
| Previous close | 63.03 |
| Open | 65.05 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 63.29 - 65.85 |
| 52-week range | 47.14 - 72.39 |
| Volume | |
| Avg. volume | 1,887 |
| Market cap | 12.496B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 38.77 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.09 (1.72%) |
| Ex-dividend date | 05 July 2023 |
| 1y target est | N/A |
- Business Wire
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2024
LUXEMBOURG, April 05, 2024--Regulatory News: Eurofins Scientific SE (Paris:ERF):
- Business Wire
The Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLC
LUXEMBOURG, April 03, 2024--Regulatory News: Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing, announces the closing of its acquisition of Ascend Clinical, LLC ("Ascend"), the largest independent laboratory for kidney dialysis testing in the United States. Founded in 2000, Ascend operates a state-of-the-art laboratory in Sunnyvale, California and employs 170 staff. The company provides highly automated chemistry, hematology, microbiology and virology testing services to di
- Business Wire
Eurofins: Purchases of Own Shares from the 18th to the 22th of March 2024
LUXEMBOURG, March 25, 2024--Regulatory News: Eurofins (Paris:ERF):
© 2024 Yahoo. All rights reserved.